Skip to content

Efficacy of combined topical treatment versus cryotherapy for the treatment of refractory warts

Comparison the efficacy of combined treatment of micro needling plus topical bleomycin versus cryotherapy for the treatment of hand and foot refractory warts

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221109056452N1
Enrollment
90
Registered
2023-02-15
Start date
2023-03-06
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand and foot wart. Plantar wart

Interventions

Intervention 1: Intervention group 1: Micro-needle is applied to patients once every two weeks. After initial micro-needling, a bleomycin solution of 1 unit/cc is prepared and placed on the site. Micr

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 65 Years

Inclusion criteria

Inclusion criteria: Treatment-resistant warts Consent to participate in the study

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Children under four years old People over 65 years old Patients under immunosuppressive treatment Patients with immunodeficiency and hypersensitivity reactions Patients with vascular diseases Patients with Raynaud's phenomenon Patients with capillary filling more than two seconds Patients with rheumatological disorders

Design outcomes

Primary

MeasureTime frame
Effectiveness of treatment according to the physician. Timepoint: 4 and 8 weeks after intervention. Method of measurement: Physician global assessment.;Effectiveness of treatment according to the patient. Timepoint: 4 and 8 weeks after intervention. Method of measurement: Patient global assessment.;Local pain. Timepoint: 4 and 8 weeks after intervention. Method of measurement: Visual analogue scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Roya Vatankhah

Tabriz University of Medical Sciences

royvtn90@gmail.com+98 44 3277 6395

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026